ASSURE Wearable Cardioverter Defibrillator (WCD) System
Kestra Medical Technologies, Inc. · Decision date Jul 27, 2021
What did the FDA approve?
FDA PMA P200037 records an approval for the ASSURE Wearable Cardioverter Defibrillator (WCD) System on 2021-07-27. The supplied database fields identify the device category as a wearable automated external defibrillator, product code MVK, with Kestra Medical Technologies, Inc. as applicant.
The statement gives the approved use in plain English: adult patients at risk for sudden cardiac arrest who are not candidates for, or refuse, an implantable defibrillator. It does not describe any supplement, manufacturing change, or separate original PMA scope beyond that labeled approval statement, so no further technical change can be inferred from the source text.
FDA approval order statement
Approval for the ASSURE system which is indicated for adult patients who are at risk for sudden cardiac arrest and are not candidates for, or refuse, an implantable defibrillator.
- Regulatory pathway
- Original PMA
- Clinical specialty
- Cardiovascular
- Decision date
- Jul 27, 2021
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P200037
- Regulatory pathway
- Premarket approval application
- Applicant
- Kestra Medical Technologies, Inc.
- Product code
- MVK
- Decision code
- APPR
- Decision date
- Jul 27, 2021
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Wearable automated external defibrillator.
- Applicant
- Kestra Medical Technologies, Inc.
- Product code
- MVK
- FDA device class
- 3
The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.
FDA decision timeline
P200037 received
Application receipt date recorded by FDA.
P200037 · FDA decision
APPR
P200037/S021 · Related supplement
ASSURE Wearable Cardioverter Defibrillator (WCD) System
P200037/S022 · Related supplement
ASSURE Wearable Cardioverter Defibrillator (WCD) System
Timeline entries are records held by MedtechLedger for P200037. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P200037
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Kestra Medical Technologies, Inc. | PMA supplement | Sep 28, 2026 | FDA | |
| Kestra Medical Technologies, Inc. | PMA supplement | Nov 4, 2026 | FDA |
Explore the linked device profile
Other records with product code MVK
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
LifeVest Wearable DefibrillatorP010030/S205 | Zoll Manufacturing Corporation | PMA supplement | Oct 6, 2026 | FDA |
LifeVest Wearable DefibrillatorP010030/S204 | Zoll Manufacturing Corporation | PMA supplement | Oct 5, 2026 | FDA |
LifeVest Wearable DefibrillatorP010030/S203 | Zoll Manufacturing Corporation | PMA supplement | Sep 29, 2026 | FDA |
LifeVest Wearable DefibrillatorP010030/S201 | Zoll Manufacturing Corporation | PMA supplement | Sep 9, 2026 | FDA |
| Zoll Manufacturing Corporation | PMA approval | Dec 18, 2001 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Kestra Medical Technologies, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 3933 Lake Washington Blvd. NE, Suite 200, Kirkland, WA, 98033
Sources and methodology
- Original FDA record: P200037
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records




